-
1دورية أكاديمية
المؤلفون: Pires da Silva, I., Zakria, D., Ahmed, T., Trojanello, C., Dimitriou, F., Allayous, C., Gerard, C., Zimmer, L., Lo, S., Michielin, O., Lebbe, C., Mangana, J., Ascierto, P.A., Johnson, D.B., Carlino, M., Menzies, A., Long, G.
المصدر: Journal for immunotherapy of cancer, vol. 10, no. 7, pp. e004610
مصطلحات موضوعية: Brain Neoplasms/drug therapy, Female, Humans, Ipilimumab/therapeutic use, Melanoma/drug therapy, Melanoma/genetics, Melanoma/pathology, Mitogen-Activated Protein Kinase Kinases/antagonists & inhibitors, Mutation, Neoplasms, Second Primary/drug therapy, Protein Kinase Inhibitors/adverse effects, Protein Kinase Inhibitors/therapeutic use, Proto-Oncogene Proteins B-raf/antagonists & inhibitors, Proto-Oncogene Proteins B-raf/genetics, Skin Neoplasms/drug therapy, Skin Neoplasms/genetics, Skin Neoplasms/pathology, immunotherapy, melanoma
وصف الملف: application/pdf
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35798536; info:eu-repo/semantics/altIdentifier/eissn/2051-1426; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_D204CE09BBCB7; https://serval.unil.ch/notice/serval:BIB_D204CE09BBCBTest; urn:issn:2051-1426; https://serval.unil.ch/resource/serval:BIB_D204CE09BBCB.P001/REF.pdfTest; http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_D204CE09BBCB7Test
الإتاحة: https://doi.org/10.1136/jitc-2022-004610Test
https://serval.unil.ch/notice/serval:BIB_D204CE09BBCBTest
https://serval.unil.ch/resource/serval:BIB_D204CE09BBCB.P001/REF.pdfTest
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_D204CE09BBCB7Test -
2دورية أكاديمية
المؤلفون: Bhave, P., Ahmed, T., Lo, S.N., Shoushtari, A., Zaremba, A., Versluis, J.M., Mangana, J., Weichenthal, M., Si, L., Lesimple, T., Robert, C., Trojanello, C., Wicky, A., Heywood, R., Tran, L., Batty, K., Dimitriou, F., Stansfeld, A., Allayous, C., Schwarze, J.K., Mooradian, M.J., Klein, O., Mehmi, I., Roberts-Thomson, R., Maurichi, A., Yeoh, H.L., Khattak, A., Zimmer, L., Blank, C.U., Ramelyte, E., Kähler, K.C., Roy, S., Ascierto, P.A., Michielin, O., Lorigan, P.C., Johnson, D.B., Plummer, R., Lebbe, C., Neyns, B., Sullivan, R., Hamid, O., Santinami, M., McArthur, G.A., Haydon, A.M., Long, G.V., Menzies, A.M., Carlino, M.S.
المصدر: Journal for immunotherapy of cancer, vol. 10, no. 7, pp. e004668
مصطلحات موضوعية: Humans, Ipilimumab/pharmacology, Ipilimumab/therapeutic use, Melanoma/drug therapy, Prospective Studies, Retrospective Studies, Skin Neoplasms, CTLA-4 Antigen, Immunotherapy, Melanoma, Programmed Cell Death 1 Receptor
وصف الملف: application/pdf
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35793872; info:eu-repo/semantics/altIdentifier/eissn/2051-1426; https://serval.unil.ch/notice/serval:BIB_B4F52EB38286Test; urn:issn:2051-1426; https://serval.unil.ch/resource/serval:BIB_B4F52EB38286.P001/REF.pdfTest
الإتاحة: https://doi.org/10.1136/jitc-2022-004668Test
https://serval.unil.ch/notice/serval:BIB_B4F52EB38286Test
https://serval.unil.ch/resource/serval:BIB_B4F52EB38286.P001/REF.pdfTest